Feasibility of whole-body MRI for detecting metastatic myxoid liposarcoma: A case series

Orthopedics

Volumn 34, Issue 11, 2011, Pages

  Seo, Sung Wook ^a   Kwon, Jong Won ^a   Jang, Sung Won ^a   Jang, Seung Pil ^a   Park, Youn Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE TISSUE; CASE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTATIC MYXOID LIPOSARCOMA; MYXOSARCOMA; NEEDLE BIOPSY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; SENSITIVITY AND SPECIFICITY; SOFT TISSUE; WHOLE BODY MRI;

ADULT; AGED; BONE NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIPOSARCOMA, MYXOID; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SOFT TISSUE NEOPLASMS; WHOLE BODY IMAGING; YOUNG ADULT;

EID: 81255162564     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20110922-15     Document Type: Article

References (21)

1. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJR Am J Roentgenol. 1995; 164(1):129-134.
2. Murphey MD, Arcara LK, Fanburg-Smith J. From the archives of the AFIP: imaging of musculoskeletal liposarcoma with radiologic- pathologic correlation. Radiographics. 2005; 25(5):1371-1395. (Pubitemid 41695351)
3. Chang HR, Hajdu SI, Collin C, Brennan MF. The prognostic value of histologic subtypes in primary extremity liposarcoma. Cancer. 1989; 64(7):1514-1520. (Pubitemid 19238971)
4. Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999; 85(1):85-92. (Pubitemid 29031360)
5. Peterson JJ, Kransdorf MJ, Bancroft LW, O'Connor MI. Malignant fatty tumors: classifi cation, clinical course, imaging appearance and treatment [published online ahead of print June 11, 2003]. Skeletal Radiol. 2003; 32(9):493-503. (Pubitemid 37161566)
6. Schwab JH, Boland P, Guo T, et al. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread [published online ahead of print January 26, 2007]. Ann Surg Oncol. 2007; 14(4):1507-14. (Pubitemid 46536828)
7. Schwab JH, Boland PJ, Antonescu C, Bilsky MH, Healey JH. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging. Cancer. 2007; 110(8):1815-1822. (Pubitemid 47557307)
8. Sheah K, Ouellette HA, Torriani M, Nielsen GP, Kattapuram S, Bredella MA. Metastatic myxoid liposarcomas: imaging and histopathologic findings [published online ahead of print December 21, 2007]. Skeletal Radiol. 2008; 37(3):251-258.
9. Young H, Baum R, Cremerius U, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999; 35(13):1773-1782. (Pubitemid 29512308)
10. Conill C, Setoain X, Colomo L, et al. Diagnostic efficacy of bone scintigraphy, magnetic resonance imaging, and positron emission tomography in bone metastases of myxoid liposarcoma. J Magn Reson Imaging. 2008; 27(3):625-628. (Pubitemid 351354750)
11. Kattapuram SV, Khurana JS, Scott JA, el- Khoury GY. Negative scintigraphy with positive magnetic resonance imaging in bone metastases. Skeletal Radiol. 1990; 19(2):113-116. (Pubitemid 20057251)
12. Schwab JH, Healey JH. FDG-PET lacks sufficient sensitivity to detect myxoid liposarcoma spinal metastases detected by MRI. Sarcoma. 2007; (2007):36785.
13. Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: evaluation of patients for metastases [published online ahead of print August 18, 2004]. Radiology. 2004; 233(1):139-148. (Pubitemid 39280968)
14. Gayed I, Vu T, Johnson M, Macapinlac H, Podoloff D. Comparison of bone and 2-deoxy- 2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer. Mol Imaging Biol. 2003; 5(1):26-31. (Pubitemid 36596542)
15. Kim MR, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY. 18F- fluorodeoxyglucosepositron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract [published online ahead of print March 12, 2007]. Oral Oncol. 2008; 44(2):148-152. (Pubitemid 351179658)
16. Liu FY, Yen TC, Chen MY, et al. Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging. Cancer. 2009; 115(23):5470-5480.
17. Mahner S, Schirrmacher S, Brenner W, et al. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-Dglucose, conventional imaging and computed tomography for staging of breast cancer [published online ahead of print March 19, 2008]. Ann Oncol. 2008; 19(7):1249-1254. (Pubitemid 351911953)
18. Ohno Y, Koyama H, Onishi Y, et al. Nonsmall cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/ CT [published online ahead of print June 6, 2008]. Radiology. 2008; 248(2):643-654.
19. Schmidt GP, Schoenberg SO, Schmid R, et al. Screening for bone metastases: whole-body MRI using a 32-channel system versus dualmodality PET-CT [published online ahead of print September 2, 2006]. Eur Radiol. 2007; 17(4):939-949. (Pubitemid 46766875)
20. Stecco A, Romano G, Negru M, et al. Wholebody diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study [in English, Italian] [published online ahead of print December 11, 2008]. Radiol Med. 2009; 114(1):1-17.
21. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, wholebody FDG-PET/CT, and bone scintigraphy. J Magn Reson Imaging. 2009; 30(2):298-308.